Esophageal Variceal Bleeding
📧 Sign up to get email alerts when something new happens for Esophageal Variceal Bleeding.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Endoscopic Hemostatic and Sedative Treatment of Esophageal and Gastric Variceal Bleeding [Phase 4]
A Phase 4 clinical trial update exploring endoscopic hemostatic methods and sedative treatment for esophageal and gastric variceal bleeding.
-
FDA approval · 2022-06-07FDA Approved: NADOLOL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Nadolol submitted by Aurobindo Pharma Limited under the ANDA, approving updated labeling for…
-
CLINICAL_TRIALS trial_result · 2019-09-30Clinical Trial Update: Hepatic Venous Pressure Gradient-guided Versus Standard Beta-blocker Therapy in Primary Prevention of Variceal Bleeding [Phase 3]
Phase 3 trial comparing hepatic venous pressure gradient-guided beta-blocker therapy to standard beta-blocker therapy for primary prevention…
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: 2- Day vs. 5- Day Terlipressin and Ceftriaxone in the Control Acute Gastroesophageal Variceal Hemorrhage [Phase 4]
Phase 4 trial update comparing 2-day vs 5-day terlipressin with ceftriaxone for control of acute esophageal variceal hemorrhage; current sta…
-
CLINICAL_TRIALS trial_result · 2019-01-17Clinical Trial Update: Early TIPS With Polytetrafluoroethylene (PTFE) Covered Stents for Acute Variceal Bleeding in Patients With Advanced Cirrhosis [NA]
Clinical trial update on early transjugular intrahepatic portosystemic shunt (TIPS) using PTFE-covered stents for acute variceal bleeding in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Comparison of Early Vs Delayed Feeding on Rebleeding Following Endoscopic Ligation for Acute Esophageal Variceal Bleeding
A completed clinical trial comparing early versus delayed feeding after endoscopic ligation for acute esophageal variceal bleeding.
-
CLINICAL_TRIALS withdrawal · 2018-07-24Clinical Trial Update: Carvedilol vs Band Ligation vs Combination Therapy for Primary Prophylaxis of Variceal Bleeding [Phase 3]
Phase 3 trial comparing carvedilol, endoscopic band ligation, and combination therapy for primary prophylaxis of variceal bleeding in portal…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Rifaximin in Patients With Gastroesophageal Variceal Bleeding [NA]
Clinical trial update notes the completion of a rifaximin study in patients with gastroesophageal variceal bleeding due to cirrhosis.
-
CLINICAL_TRIALS trial_result · 2018-04-24Clinical Trial Update: Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection [Phase 3]
This Phase 3 trial compares endoscopic injection sclerotherapy with N-butyl-2-cyanoacrylate injection for treating bleeding esophageal varic…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: RCT to Determine the Efficacy of Combining Hemospray With Medical Treatment in Acute Variceal Bleeding [NA]
A randomized trial investigating whether adding Hemospray to standard medical therapy improves outcomes in acute variceal bleeding has compl…
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: Endoscopic Band Ligation (EBL) Versus Propranolol for Primary Prophylaxis of Variceal Bleeding [Phase 4]
Phase 4 clinical trial evaluating Endoscopic Band Ligation versus Propranolol for primary prevention of variceal bleeding in patients with c…
-
FDA approval · 2017-07-10FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Sagent Pharmaceuticals)
FDA approves a supplemental application for Octreotide Acetate submitted by Sagent Pharmaceuticals.
-
FDA approval · 2017-06-27FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Meitheal Pharmaceuticals, Inc.)
The FDA approved Meitheal Pharmaceuticals' supplemental application for octreotide acetate. This approval authorizes a generic octreotide ac…
-
FDA approval · 2017-06-02FDA Approved: NADOLOL — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal's original application for a generic nadolol, a non-selective beta-blocker used to treat hypertension and to prevent…
-
CLINICAL_TRIALS trial_result · 2016-12-26Clinical Trial Update: Time Interval for Endoscopic Variceal Ligation [Phase 4]
This Phase 4 trial evaluated the time interval for endoscopic variceal ligation in patients with variceal bleeding. Results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2016-11-16Clinical Trial Update: Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal Bleeding [NA]
A clinical trial investigating rifaximin for treatment of cirrhotic gastroesophageal variceal bleeding; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV [Phase 3]
Phase 3 trial update evaluating transjugular intrahepatic portosystemic shunt (TIPS) to prevent variceal rebleeding in cirrhotic patients wi…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Vasoactive Drugs in Real World Practice [Phase 4]
Phase 4 clinical trial update on vasoconstrictor drugs used in real-world management of acute esophageal variceal bleeding; the study is com…
-
CLINICAL_TRIALS research · 2016-03-01Clinical Trial Update: The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding [Phase 4]
This Phase 4 trial compares carvedilol to endoscopic therapy for primary prevention of high-risk esophageal and gastric variceal bleeding in…
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: TIPS With 8- OR 10-mm Covered Stent for Preventing Variceal Rebleeding [NA]
A completed clinical trial evaluated using 8- or 10-mm covered stents for transjugular intrahepatic portosystemic shunt (TIPS) to prevent va…
-
FDA approval · 2015-09-16FDA Approved: NADOLOL — Original Application (Aurobindo Pharma Limited)
FDA approved Nadolol tablets as a generic drug under an Original Application (ANDA 201893) from Aurobindo Pharma Limited. This approval make…
-
CLINICAL_TRIALS trial_result · 2015-08-31Clinical Trial Update: Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis for Variceal Bleeding [Phase 4]
A Phase 4 trial comparing 3-day versus 7-day intravenous ceftriaxone prophylaxis for variceal bleeding has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding [Phase 3]
A Phase 3 clinical trial evaluates whether adding a statin to standard therapy reduces recurrent hemorrhage in patients with cirrhosis and p…
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal Bleeding [Phase 4]
A Phase 4 trial comparing carvedilol and propranolol in cirrhotic patients with variceal bleeding; the current status of the study is unknow…
-
CLINICAL_TRIALS trial_result · 2015-02-05Clinical Trial Update: Self-expandable Esophageal Stent Versus Balloon Tamponade in Refractory Esophageal Variceal Bleeding. [Phase 3]
Phase 3 trial comparing self-expandable esophageal stents to balloon tamponade for refractory esophageal variceal bleeding has completed.